| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | MAST THERAPEUTICS INC COM | 500,000 | 315,000 | 0.15% | ||
| 2 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 25,000 | 375,000 | 0.17% | ||
| 3 | SUNSHINE HEART INC | 75,000 | 420,000 | 0.20% | Call | |
| 4 | SUNSHINE HEART INC | 100,000 | 560,000 | 0.26% | ||
| 5 | FLEXION THERAPEUTICS INC | 50,000 | 674,000 | 0.31% | ||
| 6 | DEPOMED INC | 50,000 | 695,000 | 0.32% | Put | |
| 7 | SORRENTO THERAPEUTICS INC COM NEW | 130,000 | 878,000 | 0.41% | ||
| 8 | LA JOLLA PHARMACEUTICAL CO | 100,000 | 918,000 | 0.43% | ||
| 9 | ENTEROMEDICS INC | 600,000 | 936,000 | 0.44% | ||
| 10 | Egalet Corp | 75,000 | 984,000 | 0.46% | ||
| 11 | ACHAOGEN INC COM | 75,000 | 1,047,000 | 0.49% | ||
| 12 | DYAX CORP COM CVR | 117,500 | 1,128,000 | 0.53% | ||
| 13 | NEWLINK GENETICS CORP COM | 50,000 | 1,328,000 | 0.62% | ||
| 14 | AVANIR PHARMACEUTICALS INC CL | 250,000 | 1,410,000 | 0.66% | ||
| 15 | IMPAX LABORATORIES INC | 50,000 | 1,500,000 | 0.70% | Put | |
| 16 | TESARO INCORPORATED | 50,000 | 1,556,000 | 0.73% | ||
| 17 | LIGAND PHARMACEUTICALS INC | 25,000 | 1,557,000 | 0.73% | Put | |
| 18 | VANDA PHARMACEUTICALS INC COM | 100,000 | 1,618,000 | 0.75% | ||
| 19 | SUPERNUS PHARMACEUTICALS INC | 150,000 | 1,642,000 | 0.77% | Call | |
| 20 | NPS Pharmaceuticals, Inc. | 52,500 | 1,736,000 | 0.81% | ||
| 21 | DEPOMED INC | 125,000 | 1,738,000 | 0.81% | ||
| 22 | PUMA BIOTECHNOLOGY | 27,500 | 1,815,000 | 0.85% | ||
| 23 | ULTRAGENYX PHARMACEUTICAL INC COM | 41,800 | 1,876,000 | 0.88% | ||
| 24 | NOVADAQ TECHNOLOGIES INC | 120,000 | 1,978,000 | 0.92% | ||
| 25 | Esperion Therapeutics Inc | 125,000 | 1,980,000 | 0.92% | ||
| 26 | BIOMARIN PHARMACEUTICAL INC | 32,500 | 2,022,000 | 0.94% | ||
| 27 | ABBOTT LABS | 50,000 | 2,045,000 | 0.95% | Call | |
| 28 | EDWARDS LIFESCIENCES CORP | 25,000 | 2,146,000 | 1.00% | Put | |
| 29 | IMPAX LABORATORIES INC | 75,000 | 2,249,000 | 1.05% | ||
| 30 | CIGNA CORPORATION | 25,000 | 2,299,000 | 1.07% | ||
| 31 | TEVA PHARMACEUTICAL INDS LTD | 50,000 | 2,621,000 | 1.22% | ||
| 32 | WRIGHT MEDICAL GROUP NV | 85,000 | 2,669,000 | 1.24% | ||
| 33 | SPECTRANETICS CORP | 125,000 | 2,860,000 | 1.33% | ||
| 34 | WRIGHT MEDICAL GROUP N.V. | 125,000 | 2,923,000 | 1.36% | ||
| 35 | AMGEN INC | 25,000 | 2,959,000 | 1.38% | Call | |
| 36 | ENDOLOGIX INC | 195,000 | 2,966,000 | 1.38% | ||
| 37 | LIGAND PHARMACEUTICALS INC | 50,000 | 3,115,000 | 1.45% | ||
| 38 | VERTEX PHARMACEUTICALS INC | 35,000 | 3,314,000 | 1.55% | Call | |
| 39 | SALIX PHARMACEUTICALS INC | 27,500 | 3,392,000 | 1.58% | ||
| 40 | CELLDEX THERAPEUTICS INC NEW | 210,000 | 3,427,000 | 1.60% | ||
| 41 | AERIE PHARMACEUTICALS INC COM | 145,700 | 3,609,000 | 1.68% | ||
| 42 | ST JUDE MED INC | 52,500 | 3,636,000 | 1.70% | ||
| 43 | ACCELERON PHARMA INC | 110,000 | 3,737,000 | 1.74% | ||
| 44 | ALEXION PHARMACEUTIC | 25,000 | 3,906,000 | 1.82% | ||
| 45 | TENET HEALTHCARE CORP | 85,000 | 3,990,000 | 1.86% | ||
| 46 | HORIZON PHARMA PLC | 255,000 | 4,035,000 | 1.88% | ||
| 47 | SUPERNUS PHARMACEUTICALS INC | 375,000 | 4,107,000 | 1.92% | ||
| 48 | ALKERMES PLC | 85,000 | 4,278,000 | 2.00% | ||
| 49 | CELGENE CORP | 50,000 | 4,294,000 | 2.00% | Put | |
| 50 | PERRIGO CO PLC | 30,000 | 4,373,000 | 2.04% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001597549-14-000004, filed 2014.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
